The Technical Analyst
Select Language :
Elekta AB (publ) [EKTA-B.ST]

Exchange: STO Sector: Healthcare Industry: Medical Instruments & Supplies

Elekta AB (publ) Price, Forecast, Insider, Ratings, Fundamentals & Signals

Elekta AB (publ) is listed at the  Exchange

-0.60% SEK82.25

America/New_York / 17 mai 2024 @ 11:29


Elekta AB (publ): Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 30 194 mill
EPS: 3.75
P/E: 21.93
Earnings Date: Jun 05, 2024
SharesOutstanding: 367.10 mill
Avg Daily Volume: 0.985 mill
RATING 2024-05-17
A+
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Buy
Return On Asset: Buy
DE: Buy
P/E: Buy
Price To Book: Buy
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
1.11x
Company: PE 21.93 | sector: PE 19.76
PE RATIO: COMPANY / INDUSTRY
1.06x
Company: PE 21.93 | industry: PE 20.76
DISCOUNTED CASH FLOW VALUE
SEK36.62
(-55.48%) SEK-45.63
Date: 2024-05-18
Expected Trading Range (DAY)

SEK 80.20 - 84.31

( +/- 2.50%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - SEK82.25
Forecast 2: 16:00 - SEK82.25
Forecast 3: 16:00 - SEK82.25
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price SEK82.25 (-0.60% )
Volume 0.303 mill
Avg. Vol. 0.985 mill
% of Avg. Vol 30.74 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Elekta AB (publ)

Last 12 Months

Last 12 months chart data with high, low, open and close for Elekta AB (publ)

RSI

Intraday RSI14 chart for Elekta AB (publ)

Last 10 Buy & Sell Signals For EKTA-B.ST

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Elekta AB (publ)

EKTA-B.ST

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Last 10 Buy Signals

Date Signal @
UNCXUSDMay 18 - 23:06296.89
FRAXUSDMay 18 - 23:04$0.997
STSOLUSDMay 18 - 23:00203.20
LEASHUSDMay 18 - 23:00398.49
BGBUSDMay 18 - 22:591.097
BOBAUSDMay 18 - 23:000.342
MPLUSDMay 18 - 22:5413.95
ERNUSDMay 18 - 22:55$4.62
GOHMUSDMay 18 - 22:533 281.55
PROPCUSDMay 18 - 22:493.00

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.